Dermatophytosis. A review of diagnosis and current therapy.
Inhibition of fungal growth and accelerated keratolysis are the necessary ingredients of dermatophyte therapy. Often, the primary fungus is destroyed by secondary bacterial invasion or the body's immune response. Clinicians must recognize this possibility and, in such instances, treat the bacterial infection or immune response rather than the suspected dermatophyte.
D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage; D003881:Dermatomycoses / Q000175:diagnosis* / Q000188:drug therapy; D005533:Foot Dermatoses / Q000175:diagnosis*; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008864:Microsporum; D014005:Tinea / Q000175:diagnosis / Q000188:drug therapy; D014008:Tinea Pedis / Q000175:diagnosis / Q000188:drug therapy
D000935:Antifungal Agents; D006118:Griseofulvin; D007654:Ketoconazole